« Return to News | Awards & Advancement

AMRI names new president for AMRI Europe

Wednesday, May 23, 2012 12:05 PM

AMRI, a global contract research and manufacturing organization, has appointed Ian Shott as president of AMRI Europe.

In the newly created role, Shott will be responsible for AMRI's business operations in Europe, including the company's site in Wales, U.K., and work closely with AMRI's European-based business development team. As the founder of Excelsyn, acquired by AMRI in 2010, and with more than 20 years experience working with global pharmaceutical, biotechnology and chemical companies, Shott is well-fit to lead AMRI's sales growth in European markets, as well as the worldwide effort to continue to expand revenue growth at the Wales manufacturing location.

Shott also serves as managing director of Shott Consulting, where he provides consulting services to the health care and chemical industries, as well as leading industry boards for the British government in science, technology, innovation and business development.

Perviously, he has held executive board posts at RhodiaChirex in France, Chirex in the U.S., Lonza in Switzerland, and Astra Zeneca in the U.K. He has been particularly involved in creating and/or transforming businesses by a combination of break out development, culture change, organic growth, internal re-engineering and external merger, acquisition and divestment.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.